SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Quantum-Si incorporated QSIAW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Quantum-Si incorporated (QSIAW) is a Biotechnology company in the Healthcare sector, currently trading at $0.10. It has a SharesGrow Score of 47/100, indicating a mixed investment profile with 3 out of 7 criteria passed.

Valuation: QSIAW trades at a trailing Price-to-Earnings (P/E) of -1.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.12.

Financials: revenue is $2M, +81.1%/yr average growth. Net income is $101M (loss), growing at +8.8%/yr. Net profit margin is -4160.1% (negative). Gross margin is -135.5% (-180.6 pp trend).

Balance sheet: total debt is $4M against $220M equity (Debt-to-Equity (D/E) ratio 0.02, conservative). Current ratio is 7.64 (strong liquidity). Debt-to-assets is 1.7%. Total assets: $246M.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 83/100 (Pass), Past 0/100 (Fail), Health 100/100 (Pass), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

QSIAW SharesGrow Score Overview

73/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 83/100

Financials — average growth

PAST 0/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 0/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — QSIAW

QSIAW trades at a trailing Price-to-Earnings (P/E) of -1.4 (S&P 500 average ~25). Forward PEG 0.12 — Peter Lynch undervalued (≤1.0). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

QSIAW: +81.1%/yr revenue is, +8.8%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

Balance sheet QSIAW: Debt-to-Equity (D/E) ratio 0.02 (conservative), Current ratio is 7.64 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

No analyst coverage available for this stock.

QSIAW: Net profit margin is -4160.1%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.07-0.44

Volume5.98K

Avg Volume (30D)35.48K

Market Cap$21.63M

Beta (1Y)3.09

Share Statistics

EPS (TTM)-0.51

Shares Outstanding$197.77M

Employees149

CEOJeffrey Alan Hawkins

Financial Highlights & Ratios

Revenue (TTM)$2.44M

Gross Profit$-3.3M

EBITDA$-92.59M

Net Income$-101.34M

Operating Income$-97.05M

Total Cash$162.91M

Total Debt$4.17M

Net Debt$-17.47M

Total Assets$245.61M

Price / Earnings (P/E)-0.2

Price / Sales (P/S)8.88

Analyst Forecast

Company Info

CountryUS

ExchangeNASDAQ Global Market

CurrencyUSD

ISINUS74765K1135

Price Chart

QSIAW

Quantum-Si incorporated ↗ · NASDAQ Global Market

Healthcare • Biotechnology

0.07 52WK RANGE 0.44

People Also View

AST SpaceMobile, Inc.

Origin Materials, Inc.

NRx Pharmaceuticals, Inc.

indie Semiconductor, Inc.

Eli Lilly and Company

Johnson & Johnson

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message